<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34834958</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>COVEVOL: Natural Evolution at 6 Months of COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2151</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13112151</ELocationID><Abstract><AbstractText>Many studies have investigated post-COVID symptoms, but the predictors of symptom persistence remain unknown. The objective was to describe the natural course of the disease at 6 months and to identify possible factors favoring the resurgence or persistence of these symptoms. COVEVOL is a retrospective observational descriptive study of 74 patients. All patients with positive SARS-CoV-2 PCR from March 2020 were included. We compared a group with symptom persistence (PS group) with another group without symptom persistence (no-PS group). Fifty-three out of seventy-four patients (71.62%) described at least one persistent symptom at 6 months of SARS-CoV-2 infection. In the PS group, 56.6% were women and the average age was 54.7 years old [21-89.2] &#xb1; 16.9. The main symptoms were asthenia (56.6%, <i>n</i> = 30), dyspnea (34%, <i>n</i> = 18), anxiety (32.1% <i>n</i> = 17), anosmia (24.5%, <i>n</i> = 13) and agueusia (15.1% <i>n</i> = 8). Ten patients (13.51%) presented a resurgence in symptoms. Patients in the PS group were older (<i>p</i> = 0.0048), had a higher BMI (<i>p</i> = 0.0071), and were more frequently hospitalized (<i>p</i> = 0.0359) compared to the no-PS group. Odynophagia and nasal obstruction were less present in the inaugural symptoms of COVID-19 in the PS group (<i>p</i> = 0.0202 and <i>p</i> = 0.0332). Persistent post-COVID syndromes are common and identification of contributing factors is necessary for understanding this phenomenon and appropriate management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Messin</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Infectious Disease Department, Nord Franche-Comt&#xe9; Hospital, 90400 Trevenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puyraveau</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Investigation Center, Jean Minjoz University Hospital of Besan&#xe7;on, 25000 Besancon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benabdallah</LastName><ForeName>Yousri</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Nord Franche-Comt&#xe9; Hospital, 90400 Trevenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lepiller</LastName><ForeName>Quentin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Virology Department, Jean Minjoz University Hospital of Besan&#xe7;on, 25000 Besancon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gendrin</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-9220-9359</Identifier><AffiliationInfo><Affiliation>Infectious Disease Department, Nord Franche-Comt&#xe9; Hospital, 90400 Trevenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zayet</LastName><ForeName>Souheil</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3177-9806</Identifier><AffiliationInfo><Affiliation>Infectious Disease Department, Nord Franche-Comt&#xe9; Hospital, 90400 Trevenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klopfenstein</LastName><ForeName>Timoth&#xe9;e</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Infectious Disease Department, Nord Franche-Comt&#xe9; Hospital, 90400 Trevenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toko</LastName><ForeName>Lynda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Infectious Disease Department, Nord Franche-Comt&#xe9; Hospital, 90400 Trevenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierron</LastName><ForeName>Alix</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Disease Department, Nord Franche-Comt&#xe9; Hospital, 90400 Trevenans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Royer</LastName><ForeName>Pierre-Yves</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Infectious Disease Department, Nord Franche-Comt&#xe9; Hospital, 90400 Trevenans, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anosmia</Keyword><Keyword MajorTopicYN="N">anxiety</Keyword><Keyword MajorTopicYN="N">asthenia</Keyword><Keyword MajorTopicYN="N">dyspnea</Keyword><Keyword MajorTopicYN="N">persistent symptoms</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">&#x201c;long COVID&#x201d;</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34834958</ArticleId><ArticleId IdType="pmc">PMC8619893</ArticleId><ArticleId IdType="doi">10.3390/v13112151</ArticleId><ArticleId IdType="pii">v13112151</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shereen M.A., Khan S., Kazmi A., Bashir N., Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J. Adv. Res. 2020;24:91&#x2013;98. doi: 10.1016/j.jare.2020.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2020.03.005</ArticleId><ArticleId IdType="pmc">PMC7113610</ArticleId><ArticleId IdType="pubmed">32257431</ArticleId></ArticleIdList></Reference><Reference><Citation>Allocution Liminaire du Directeur G&#xe9;n&#xe9;ral de l&#x2019;OMS Lors du Point Presse sur la COVID-19. 2020.  [(accessed on 11 March 2020)].  Available online:  https://www.who.int/fr/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19.</Citation></Reference><Reference><Citation>Desvaux &#xc9;., Faucher J.-F. Covid-19: Aspects cliniques et principaux &#xe9;l&#xe9;ments de prise en charge. Rev. Francoph. Lab. 2020;2020:40&#x2013;47. doi: 10.1016/S1773-035X(20)30312-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1773-035X(20)30312-9</ArticleId><ArticleId IdType="pmc">PMC7603941</ArticleId><ArticleId IdType="pubmed">33163103</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W., Liang W., Zhao Y., Liang H., Chen Z., Li Y. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis.  [(accessed on 10 February 2021)];Eur. Respir. J. 2020 55:2000547. doi: 10.1183/13993003.00547-2020. Available online:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098485/</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00547-2020</ArticleId><ArticleId IdType="pmc">PMC7098485</ArticleId><ArticleId IdType="pubmed">32217650</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus: Chiffres Cl&#xe9;s et &#xc9;volution de la COVID-19 en France et dans le Monde.  [(accessed on 10 February 2021)].  Available online:  https://dossiers/coronavirus-covid-19/coronavirus-chiffres-cles-et-evolution-de-la-covid-19-en-france-et-dans-le-monde.</Citation></Reference><Reference><Citation>Zaffina S., Lanteri P., Gilardi F., Garbarino S., Santoro A., Vinci M.R. Recurrence, Reactivation, or Inflammatory Rebound of SARS-CoV-2 Infection With Acute Vestibular Symptoms: A Case Report and Revision of Literature. Front. Hum. Neurosci. 2021;15:444. doi: 10.3389/fnhum.2021.666468.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2021.666468</ArticleId><ArticleId IdType="pmc">PMC8385757</ArticleId><ArticleId IdType="pubmed">34456694</ArticleId></ArticleIdList></Reference><Reference><Citation>Suivi des patients convalescents de la COVID-19 par le m&#xe9;decin g&#xe9;n&#xe9;raliste. Bull. Acad. Natl. Med. 2020;204:769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7354260</ArticleId><ArticleId IdType="pubmed">32836268</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., Danielsen M.E., &#xe1; Steig B., Gaini S. Long COVID in the Faroe Islands&#x2014;A longitudinal study among non-hospitalized patients. Clin. Infect. Dis. 2020:ciaa1792. doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>La&#xeb;titia L.G. R&#xe9;ponses Rapides Dans le Cadre de la Covid-19: Sympt&#xf4;mes Prolong&#xe9;s Suite &#xe0; une Covid-19 de l&#x2019;adulte&#x2014;Diagnostic et Prise en Charge.  [(accessed on 4 October 2021)].  Available online:   https://www.has-sante.fr/upload/docs/application/pdf/2021-02/20rr430_covid_19_symptomes_prolonges_post_cd.pdf.</Citation></Reference><Reference><Citation>Yelin D., Wirtheim E., Vetter P., Kalil A.C., Bruchfeld J., Runold M. Long-term consequences of COVID-19: Research needs. Lancet Infect. Dis. 2020;20:1115&#x2013;1117. doi: 10.1016/S1473-3099(20)30701-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30701-5</ArticleId><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Osikomaiya B., Erinoso O., Wright K.O., Odusola A.O., Thomas B., Adeyemi O. &#x2018;Long COVID&#x2019;: Persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC Infect. Dis. 2021;21:304. doi: 10.1186/s12879-020-05716-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05716-x</ArticleId><ArticleId IdType="pmc">PMC7993075</ArticleId><ArticleId IdType="pubmed">33765941</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 2021;27:89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Barrett K.M.S., Riffle S., Bolze A., Neveux I., Dabe S. Long-term COVID-19 symptoms in a large unselected population. medRxiv. 2020 doi: 10.1101/2020.10.07.20208702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S., Rosell A., Phillipson M., Mangsbo S.M., Nilsson P., Hober S. Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. JAMA. 2021;325:2015. doi: 10.1001/jama.2021.5612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Kelly J.D., Lu S., Goldberg S.A., Davidson M.C., Mathur S. Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19. medRxiv. 2021 doi: 10.1101/2021.03.11.21252311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.11.21252311</ArticleId></ArticleIdList></Reference><Reference><Citation>Leth S., Gunst J.D., Mathiasen V., Hansen K., S&#xf8;gaard O., &#xd8;stergaard L. Persistent Symptoms in Patients Recovering From COVID-19 in Denmark. Open Forum. Infect. Dis. 2021;8:ofab042. doi: 10.1093/ofid/ofab042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab042</ArticleId><ArticleId IdType="pmc">PMC7928683</ArticleId><ArticleId IdType="pubmed">33875970</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., The Gemelli Against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network&#x2014;United States, March&#x2013;June 2020.  [(accessed on 18 April 2021)];MMWR Morb. Mortal. Wkly. Rep. 2020 69:993. doi: 10.15585/mmwr.mm6930e1. Available online:  https://www.cdc.gov/mmwr/volumes/69/wr/mm6930e1.htm.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Armange L., B&#xe9;n&#xe9;zit F., Picard L., Pronier C., Guillot S., Lentz P.-A. Prevalence and characteristics of persistent symptoms after non-severe COVID-19: A prospective cohort study. Eur. J. Clin. Microbiol. Infect. Dis. 2021 doi: 10.1007/s10096-021-04261-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-021-04261-y</ArticleId><ArticleId IdType="pmc">PMC8064701</ArticleId><ArticleId IdType="pubmed">33893570</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.-M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J. Post-acute COVID-19 Syndrome. Incidence and risk factors: A Mediterranean cohort study.  [(accessed on 29 January 2021)];J. Infect. 2021 82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004. Available online:  http://www.sciencedirect.com/science/article/pii/S0163445321000098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Herck M.V., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome?  [(accessed on 1 April 2021)];ERJ Open Res. 2020 6:00542&#x2013;2020. doi: 10.1183/23120541.00542-2020. Available online:  https://openres.ersjournals.com/content/6/4/00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Delfraissy J.-F., Atlani-Duault L., Benamouzig D., Bouadma L., Cauchemez S., Chirouze C. Anticiper et diff&#xe9;rencier les strat&#xe9;gies pour sortir des phases aigu&#xeb;s de l&#x2019;&#xe9;pid&#xe9;mie. MARS. 2021;94:16H00.</Citation></Reference><Reference><Citation>Petrilli C.M., Jones S.A., Yang J., Rajagopalan H., O&#x2019;Donnell L., Chernyak Y. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study. BMJ. 2020;369:m1966. doi: 10.1136/bmj.m1966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1966</ArticleId><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C. Attributes and predictors of Long-COVID: Analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv. 2020 doi: 10.1101/2020.10.19.20214494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.19.20214494</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G., Zangrillo A., Zanella A., Antonelli M., Cabrini L., Castelli A. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574. doi: 10.1001/jama.2020.5394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.5394</ArticleId><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., De Siati D.R., Horoi M., Le Bon S.D., Rodriguez A. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur. Arch. Oto-Rhino-Laryngol. 2020;277:2251&#x2013;2261. doi: 10.1007/s00405-020-05965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy R.K., Charles W.N., Sklavounos A., Dutt A., Seed P.T., Khajuria A. The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. J. Med. Virol. 2021;93:1045&#x2013;1056. doi: 10.1002/jmv.26389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26389</ArticleId><ArticleId IdType="pmc">PMC7436545</ArticleId><ArticleId IdType="pubmed">32749705</ArticleId></ArticleIdList></Reference><Reference><Citation>Klement-Frutos E., Burrel S., Pourcher V., Boutolleau D. &#xc9;tude COVL: Impact de la charge virale nasopharyng&#xe9;e du SARS-COV-2 sur l&#x2019;&#xe9;volution clinique en hospitalisation. Med. Mal. Infect. 2020;50((Suppl. 6)):S76&#x2013;S77. doi: 10.1016/j.medmal.2020.06.151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medmal.2020.06.151</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe9;ant N., Lingas G., Hingrat Q.L., Ghosn J., Engelmann I., Lepiller Q. Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.  [(accessed on 28 June 2021)];Proc. Natl. Acad. Sci. USA. 2021 118 doi: 10.1073/pnas.2017962118. Available online:  https://www.pnas.org/content/118/8/e2017962118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2017962118</ArticleId><ArticleId IdType="pmc">PMC7929555</ArticleId><ArticleId IdType="pubmed">33536313</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg P., Arora U., Kumar A., Malhotra A., Kumar S., Garg S. Risk factors for prolonged fatigue after recovery from COVID-19. J. Med. Virol. 2021;93:1926&#x2013;1928. doi: 10.1002/jmv.26774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26774</ArticleId><ArticleId IdType="pubmed">33393696</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessica L. Fatigue au Cours des Sympt&#xf4;mes Prolong&#xe9;s de la Covid-19.  [(accessed on 4 October 2021)].  Available online:  https://www.has-sante.fr/upload/docs/application/pdf/2021-02/fiche_-_fatigue.pdf.</Citation></Reference><Reference><Citation>Islam M.F., Cotler J., Jason L.A. Post-viral fatigue and COVID-19: Lessons from past epidemics. Fatigue Biomed. Health Behav. 2020;8:61&#x2013;69. doi: 10.1080/21641846.2020.1778227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2020.1778227</ArticleId></ArticleIdList></Reference><Reference><Citation>Caussy C. Ob&#xe9;sit&#xe9; et infection par la COVID-19: Une liaison dangereuse. Med. Mal. Metab. 2021;15:288&#x2013;293.</Citation></Reference><Reference><Citation>Long-Term Clinical Outcomes in Survivors of Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome Coronavirus (MERS) Outbreaks after Hospitalisation or Icu Admission: A Systematic Review and Meta-Analysis.  [(accessed on 8 July 2021)].  Available online:  http://www.medicaljournals.se/jrm/content/abstract/10.2340/16501977-2694.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>McGroder C.F., Zhang D., Choudhury M.A., Salvatore M.M., D&#x2019;Souza B.M., Hoffman E.A. Pulmonary Fibrosis 4 Months after COVID-19 Is Associated with Severity of Illness and Blood Leucocyte Telomere Length.  [(accessed on 7 June 2021)];Thorax. 2021  Available online:  https://thorax.bmj.com/content/early/2021/05/13/thoraxjnl-2021-217031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8103561</ArticleId><ArticleId IdType="pubmed">33927016</ArticleId></ArticleIdList></Reference><Reference><Citation>La&#xeb;titia G. La Dyspn&#xe9;e au Cours des Sympt&#xf4;mes Prolong&#xe9;s de la Covid-19.  [(accessed on 4 October 2021)].  Available online:  https://www.has-sante.fr/upload/docs/application/pdf/2021-02/fiche_-_dyspnee.pdf.</Citation></Reference><Reference><Citation>Wang C., Pan R., Wan X., Tan Y., Xu L., Ho C.S. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int. J. Environ. Res. Public Health. 2020;17:E1729. doi: 10.3390/ijerph17051729.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17051729</ArticleId><ArticleId IdType="pmc">PMC7084952</ArticleId><ArticleId IdType="pubmed">32155789</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62,354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8:130&#x2013;140. doi: 10.1016/S2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Beckers E., Mustin V., Ducarme M., Journe F. Prevalence and 6-month recovery of olfactory dysfunction: A multicentre study of 1363 COVID-19 patients. J. Intern. Med. 2021;290:451&#x2013;461. doi: 10.1111/joim.13209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13209</ArticleId><ArticleId IdType="pubmed">33403772</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliezer M., Hautefort C., Hamel A.-L., Verillaud B., Herman P., Houdart E. Sudden and Complete Olfactory Loss of Function as a Possible Symptom of COVID-19. JAMA Otolaryngol. Neck Surg. 2020;146:674. doi: 10.1001/jamaoto.2020.0832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2020.0832</ArticleId><ArticleId IdType="pubmed">32267483</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X., Lian J.-S., Hu J.-H., Gao J., Zheng L., Zhang Y.-M. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69:1002&#x2013;1009. doi: 10.1136/gutjnl-2020-320926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-320926</ArticleId><ArticleId IdType="pmc">PMC7133387</ArticleId><ArticleId IdType="pubmed">32213556</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiesa-Estomba C.M., Lechien J.R., Barillari M.R., Saussez S. Patterns of Gustatory Recovery in Patients Affected by the COVID-19 Outbreak. Virol. Sin. 2020;35:833&#x2013;837. doi: 10.1007/s12250-020-00272-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00272-9</ArticleId><ArticleId IdType="pmc">PMC7397964</ArticleId><ArticleId IdType="pubmed">32748131</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanif M., Haider M.A., Ali M.J., Naz S., Sundas F. Reinfection of COVID-19 in Pakistan: A First Case Report.  [(accessed on 9 January 2021)];Cureus. 2020 12:e11176. doi: 10.7759/cureus.11176. Available online:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689968/</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.11176</ArticleId><ArticleId IdType="pmc">PMC7689968</ArticleId><ArticleId IdType="pubmed">33262913</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayet S., Royer P.-Y., Toko L., Pierron A., Gendrin V., Klopfenstein T. Recurrence of COVID-19 after recovery ? A case series in health care workers, France. Microbes Infect. 2021;23:104803. doi: 10.1016/j.micinf.2021.104803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2021.104803</ArticleId><ArticleId IdType="pmc">PMC7923857</ArticleId><ArticleId IdType="pubmed">33667643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravioli S., Ochsner H., Lindner G. Reactivation of COVID-19 pneumonia: A report of two cases. J. Infect. 2020;81:e72&#x2013;e73. doi: 10.1016/j.jinf.2020.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7204684</ArticleId><ArticleId IdType="pubmed">32389787</ArticleId></ArticleIdList></Reference><Reference><Citation>Loconsole D., Passerini F., Palmieri V.O., Centrone F., Sallustio A., Pugliese S. Recurrence of COVID-19 after recovery: A case report from Italy. Infection. 2020 doi: 10.1007/s15010-020-01444-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01444-1</ArticleId><ArticleId IdType="pmc">PMC7228864</ArticleId><ArticleId IdType="pubmed">32415334</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayet S., Zahra H., Royer P.-Y., Tipirdamaz C., Mercier J., Gendrin V. Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in Nord Franche-Comt&#xe9; Hospital, France. Microorganisms. 2021;9:1719. doi: 10.3390/microorganisms9081719.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9081719</ArticleId><ArticleId IdType="pmc">PMC8401026</ArticleId><ArticleId IdType="pubmed">34442798</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanti M., Shaman J. Direct observation of repeated infections with endemic coronaviruses. J. Infect. Dis. 2021;223:409&#x2013;415. doi: 10.1093/infdis/jiaa392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa392</ArticleId><ArticleId IdType="pmc">PMC7454749</ArticleId><ArticleId IdType="pubmed">32692346</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>